Abstract
Acute myocardial infarction (AMI) is a major cause of death in the Western World (Table 1). One of the main precipitating events in AMI is the formation of an occluding thrombus in a coronary artery. The thrombus prevents blood flow to the myocardium thus reducing oxygen supply which in turn leads to an, often fatal, infarction. It is now widely accepted that early removal of the blood clot, by dissolution of the fibrin network which holds it together, is of major benefit in reducing morbidity and mortality.1 A number of fibrinolytic proteins are now in use in the clinic. One of these is tissue-type plasminogen activator (t-PA).2 t-PA is a serine protease; however, it does not dissolve fibrin directly, instead it activates plasminogen, a plasma protein, by cleaving the arg561-val562 peptide bond thus revealing the active enzyme, plasmin. Plasmin in turn dissolves fibrin and lyses the thrombus. The primary structure of t-PA was only established after cloning the mRNA as cDNA (Fig. 1).3,4 The 527 amino acid protein, like many serine proteases, consists of two chains (A and B) linked by a protease-susceptible peptide bond. The B chain carries the catalytic centre, but somewhat unusually for a serine protease, t-PA appears to be active in both single and two-chain forms. The A chain is believed to be divided into four structural domains (the finger, the growth factor and two kringles).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Marder, V. J. & Sherry, S., Thrombolytic therapy: current status. New Engl. J. Med., 318 (1988) 1512–20, 1585–95.
Rijken, D. C. & Collen, D., Purification and characterisation of the plasminogen activator secreted by human melanoma cells in culture. J. Biol. Chem., 256 (1981) 7035–41.
Pennica, D., Holmes, W. E., Kohr, W. J., Harkins, R. N., Vehar, G. A., Ward, C. A., Bennett, W. F., Yelverton, E., Seeburg, P. H., Heyneker, H. L., Goeddel, D. V. & Collen, D., Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. Nature, 301 (1983) 214–21.
Banyai, L., Varadi, A. & Patthy, L., Common evolutionary origin of the fibrin-binding structures of fibronectin and tissue-type plasminogen activator. FEBS Lett., 163 (1983) 37–41.
Patthy, L., Evolution of the proteases of blood coagulation and fibrinolysis by assembly of molecules. Cell, 41 (1985) 657–63.
Harris, T. J. R., Patel, T., Marston, F. A. O., Little, S., Emtage, J. S., Opdenakker, G., Volckaert, G., Rombauts, W., Billiau, A. and DeSomer, P., Cloning of cDNA coding for human tissue-type plasminogen activator and its expression in E. coli. Molec. Biol. Med., 3 (1986) 279–92.
Lemontt, J. F., Wei, C.-H. & Dackowski, W. R., Expression of active human uterine tissue plasminogen activator in yeast. DNA, 4 (1985) 419–28.
Upshall, A., Kumar, A. A., Bailey, M. C., Parker, M. D., Favreau, M. A., Lewison, K. P., Joseph, M. L., Maraganore, J. M. & McKnight, G. L., Secretion of active human tissue plasminogen activator from the filamentous fungus Aspergillus nidulans. Bio/Technology, 5 (1987) 1301–3.
Gordon, K., Lee, E., Vitale, J. A., Smith, A. E., Westphal, H. & Hennighausen, L., Production of human tissue plasminogen activator in transgenic mouse milk. Bio/Technology, 5 (1987) 1183–7.
Browne, M. J., Carey, J. E., Chapman, C. G., Tyrrell, A. W. R., Entwisle, C., Lawrence, G. M. P., Reavy, B., Dodd, I. & Robinson, J. H., A tissue-type plasminogen activator mutant with prolonged clearance in vivo. J. Biol. Chem., 263 (1988) 1599–602.
Bebbington, C. R. & Hentschel, C. G., The use of vectors based on gene amplification for the expression of cloned genes in mammalian cells. In DNA Cloning, a Practical Approach, Vol. III, ed. D. M. Glover, IRL Press, Oxford, 1987, pp. 163–88.
Tate, K. M., Higgins, D. L., Holmes, W. E., Winkler, M. E., Heyneker, H. L. & Vehar, G. A., Functional rôle of proteolytic cleavage at arginine275 of human tissue plasminogen activator as assessed by site-directed mutagenesis. Biochemistry, 26 (1987) 338–43.
Harris, T. J. R., Second generation plasminogen activators. Prot. Eng., 1 (1988) 449–58.
Krause, J., Catabolism of tissue-type plasminogen activator, its variants, mutants and hybrids. Fibrinolysis, 2 (1988) 133–42.
Dodd, L, Fears, R & Robinson, J. H., Isolation and preliminary characterisation of active B-chain of recombinant tissue-type plasminogen activator. Thromb. Haem., 55 (1988) 133–42.
Browne, M. J. & Robinson, J. H., European Patent Application Publication, 1987, 0 241 210.
Schnee, J. M., Runge, M. S., Matsueda, G. R., Hudson, N. W., Seidman, J. G., Haber, E. & Quertermous, T., Construction and expression of a recombinant antibody-targeted plasminogen activator. Proc. Nat. Acad. Sci., 84 (1987) 6904–8.
Lee, S. G., Kalyan, N., Wilhelm, J., Hum, W.-T., Rapparport, R., Cheng, S.-M., Dheer, S., Urbano, C., Hartzell, R. W., Ronchetti-Blume, M., Levner, M. & Hung, P. P., Construction and expression of hybrid plasminogen activators prepared from tissue-type plasminogen activator and urokinase-type plasminogen activator genes. J. Biol. Chem., 263 (1988) 2917–24.
de Vries, C., Veerman, H., Blasi, F. & Pannekoek, H., Artificial exon shuffling between tissue-type plasminogen activator and urokinase. Biochemistry, 27 (1988) 2565–72.
Pierard, L., Jacobs, P., Gheysen, D., Hoylaerts, M., Andre, B., Topisirovic, L., Cravador, A., de Foresta, F., Herzog, A., Collen, D., de Wilde, M. & Bollen, A., Mutant and chimeric recombinant plasminogen activators. J. Biol. Chem., 262 (1987) 11771–8.
Gheysen, D., Lijnan, H. R., Pierard, L., de Foresta, F., Demarsin, E., Jacobs, P., de Wilde, M., Bollen, A. & Collen, D., Characterisation of a recombinant fusion protein of the finger domain of tissue-type plasminogen activator with a truncated single chain urokinase-type plasminogen activator. J. Biol Chem., 262 (1987) 11779–84.
Robinson, J. H., Dodd, I., Esmail, A., Ferres, H. & Nunn, B., Slow clearance of acylated, hybrid thrombolytic enzymes. Thromb. Haem., 59 (1988) 421–5.
Browne, M. J., Tyrrell, A. W. R., Chapman, C. G., Carey, J. E., Glover, D. M., Grosveld, F. G., Dodd, I. & Robinson, J. H., Isolation of a human tissue-type plasminogen activator genomic DNA clone and its expression in mouse L cells. Gene, 33 (1985) 279–84.
Browne, M. J., Dodd, I., Carey, J. E., Chapman, C. G. & Robinson, J. H., Increased yield of human tissue-type plasminogen activator obtained by means of recombinant DNA technology. Thromb. Haem., 54 (1985) 422–4.
Dodd, I., Nunn, B. & Robinson, J. H., Isolation, identification and pharmacokinetic properties of human tissue-type plasminogen activator species. Thomb. Haem., 59 (1988) 523–8.
Wu, H.-L., Shi, G.-Y., Wohl, R. C. & Bender, M. L., Structure and formation of microplasmin. Proc. Nat. Acad. Sci., 84 (1987) 8793–5.
Pannekoek, H., de Vries, C. & van Zonneveld, A.-J., Mutants of human tissue-type plasminogen activator: structural aspects and functional properties. Fibrinolysis, 2 (1988) 123–32.
Gething, M. J., Adler, B., Boose, J.-A., Gerard, R. D., Madison, E. L., McGookey, D., Meidell, R. S., Roman, L. M. & Sambrook, J., Variants of human tissue-type plasminogen activator that lack specific structural domains of the heavy chain. EMBO J., 7 (1988) 2731–40.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Elsevier Science Publishers Ltd
About this chapter
Cite this chapter
Browne, M.J., Carey, J.E., Chapman, C.G., Dodd, I., Lawrence, G.M.P., Robinson, J.H. (1990). The Expression of Tissue-Type Plasminogen Activator and Related Enzymes. In: Harris, T.J.R. (eds) Protein Production by Biotechnology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1565-0_8
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1565-0_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8858-9
Online ISBN: 978-1-4613-1565-0
eBook Packages: Springer Book Archive